	Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trial. BMJ You R, Xu GQ, Ding X, Liang JH, Liu ZG, Zou X, Liu YP, Hu GY, Liu YM, Duan CY, Liu LZ, Zhang WJ, Liu Q, Li HF, Ouyang YF, Duan XT, Wang Q, Peng L, Liang JL, Feng ZK, Qin ZH, Liu X, He ZK, Zhang B, Long GX, Jiang YH, Lei F, Huang PY, Hua YJ, Chen MY. PMID: 41667193 [PubMed - indexed for MEDLINE]
	USP18 orchestrates malignant progression in nasopharyngeal carcinoma through UBR5-driven attenuation of p53 signaling. Int Immunopharmacol Yi Q, Wang D, Zhong K, Chen Z, An J, Ouyang X, Zhu W, Xin Y, Zhong J. PMID: 41633015 [PubMed - indexed for MEDLINE]
	Refining M1-Stage Stratification in De Novo Metastatic Nasopharyngeal Carcinoma Using 18F-FDG PET/CT: Preliminary Evidence. Clin Nucl Med Chen SH, Cheng NM, Fan KS, Chang PH, Lee LA, Huang SF, Kang CJ, Shen EY, Chang KP, Wu PW, Lien KH, Fang TJ, Cheng AJ, Chang JT. PMID: 41632574 [PubMed - indexed for MEDLINE]
	Analysis of Plasma Epstein-Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE-122. Cancer Med Chan ATC, Lee VHF, Hong RL, Ahn MJ, Chong WQ, Spreafico A, Kim SB, Ho GF, Caguioa PB, Ngamphaiboon N, Swaby RF, Wei B, Webber AL, Kang J, Gumuscu B, Yuan J, Siu LL. PMID: 41631899 [PubMed - indexed for MEDLINE]
	Artificial intelligence-assisted real-time nasopharyngeal cancer diagnostic model enhances rhinologist performance: a prospective multi-reader study. Ann Med He R, Jie P, Wang Z, Lu Y, Lv H, Huang Z, Liu W, Wang Y, Liu W, Lei W, Wen W, Wen Y. PMID: 41630445 [PubMed - indexed for MEDLINE]
	Comparison of Local Control and Toxicity in T4 Nasopharyngeal Carcinoma Patients Treated with Induction Chemotherapy and Intensity-Modulated Radiotherapy: Conventional vs. Hyperfractionated Regimens. Medicina (Kaunas) Hsieh HY, Lin JC, Chang HH. PMID: 41597363 [PubMed - indexed for MEDLINE]
	Efficacy and prognostic model development of immune checkpoint inhibitor rechallenge in recurrent orÂ metastatic nasopharyngeal carcinoma: a real-world study. Cancer Immunol Immunother Jiang Y, Wu J, Dong S, Zhang Z, Bei W, Zheng L, Xiang Y, Liu G. PMID: 41591431 [PubMed - indexed for MEDLINE]
	Collaborative breakthroughs in precision diagnosis and treatment of nasopharyngeal cancer: Biomarkerâ€‘driven screening and endoscopic minimally invasive surgery reshape the new paradigm of early intervention (Review). Oncol Rep Jin E, Lin W, Zeng X. PMID: 41574726 [PubMed - indexed for MEDLINE]
	Burden and Trends of Nasopharyngeal Cancer Among Younger People in the Western Pacific Region, 1990 to 2021: Findings from the 2021 Global Burden of Disease Study. J Otolaryngol Head Neck Surg Zhou L, Ma G, Jia W, Zhang Y, Wu L, Ye Y, Liu D, Li X. PMID: 41572805 [PubMed - indexed for MEDLINE]
	Improved Overall Survival Due to Reduced Waiting Time in Nasopharyngeal Cancer Patients Treated with Chemoradiotherapy in Yogyakarta, Indonesia. Asian Pac J Cancer Prev Diessen JNAV, Ekaputra E, Tan B, Stoker S, Herdini C, Dhamiyati W, Dwidanarti R, Meidania L, Kurniawan T, Yanuarta S, Indrasari SR, Fles R. PMID: 41569188 [PubMed - indexed for MEDLINE]
	Toripalimab plus concurrent chemoradiotherapy for recurrent nasopharyngeal carcinoma: A single-arm, phase 2 clinical trial. Cancer Xiao Z, Liang Z, Huang H, Qin Y, Huang S, Wei J, Guan Y, Du Y, Su F, Li K, Liu Y, Wei J, Zeng F, Li Y, Wei C, Mo Y, Yu B, Qu S. PMID: 41548086 [PubMed - indexed for MEDLINE]
	Five-year comparison of magnetic resonance imaging and endoscopy for nasopharyngeal carcinoma detection among high-risk populations undergoing screening. Cancer Zhou HN, Li T, Peng YN, Li H, Wu ZC, Fan YY, King AD, Hildesheim A, Ling W, Liu Z, Cao SM. PMID: 41548058 [PubMed - indexed for MEDLINE]
	Identification of hub genes and construction of a survival prediction model for patients with nasopharyngeal carcinoma. Sci Rep Zhu J, Feng Y, Zhu Z, Chen Y, Tang CE. PMID: 41545643 [PubMed - indexed for MEDLINE]
	Predicting high lymph node positivity risk factors in nasopharyngeal carcinoma patients: A multi-model approach. Medicine (Baltimore) Liao H, He B, Yan F. PMID: 41517768 [PubMed - indexed for MEDLINE]
	Evaluation of Anti-BNLF2b Antibody and Epstein-Barr Virus Biomarkers for the Diagnosis of Nasopharyngeal Carcinoma: A Retrospective Study. Technol Cancer Res Treat Deng H, Liu Q, Shen H, Xiao P. PMID: 41505354 [PubMed - indexed for MEDLINE]
	Auditory Preservation in Nasopharyngeal Carcinoma: Comparison of Proton and Photon Radiotherapy. Otolaryngol Head Neck Surg Lien KH, Lin CY, Chen PY, Chang JT, Chen TY, Hung SP, Lee CH, Yap WK, Hsieh CE, Hsu CL, Lee CY, Chang KP. PMID: 41503873 [PubMed - indexed for MEDLINE]
	Compassionate boron neutron capture therapy for locally recurrent nasopharyngeal cancer: A retrospective study. J Chin Med Assoc Wang LW, Hsueh Liu YW, Peir JJ, Lin KH, Lee JC, Shueng PW, Yen SH, Yang MH. PMID: 41501971 [PubMed - indexed for MEDLINE]
	Risk Factors of Malnutrition in Nasopharyngeal Carcinoma Patients Undergoing Radiotherapy and Construction of a Predictive Model. J Nutr Sci Vitaminol (Tokyo) Zhan C, Gong Z, Ji N, Ju X. PMID: 41485969 [PubMed - indexed for MEDLINE]
	Positron emission tomography-based intratumoral spatial diversity for prognosis in nasopharyngeal carcinoma. Oral Oncol Niu S, Ding J, Chen H, Zhu Z, Liao X, Hong H, Chen C, Dong J, Fei Z. PMID: 41481965 [PubMed - indexed for MEDLINE]
	Prognostic Value of Histological Subtypes and Clinical Factors in Non-Endemic Nasopharyngeal Carcinoma: A Retrospective Cohort Study. Medicina (Kaunas) Sali S, Abakay CD, Sali M, Güdücü H, Çak, Ocak B, , Co, Orhan SO, Ula, Deligönül A, Evrensel T, Çubukçu E. PMID: 41470209 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 8976

Page 1 of 449



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy